Infinity Pharmaceuticals Future Growth

How is Infinity Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

9.9%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGS:INFI - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2025	N/A	-53	N/A	N/A	1
12/31/2024	N/A	-46	N/A	N/A	1
12/31/2023	2	-42	N/A	N/A	2
9/30/2022	3	-47	-43	-43	N/A
6/30/2022	2	-47	-42	-42	N/A
3/31/2022	2	-46	-41	-41	N/A
12/31/2021	2	-45	-41	-41	N/A
9/30/2021	2	-44	-39	-39	N/A
6/30/2021	2	-43	-39	-39	N/A
3/31/2021	2	-41	-37	-37	N/A
12/31/2020	2	-40	-36	-36	N/A
9/30/2020	2	-41	-37	-36	N/A
6/30/2020	1	-43	-40	-38	N/A
3/31/2020	1	-44	-40	-38	N/A
12/31/2019	3	-47	-44	-42	N/A
9/30/2019	3	-44	-18	-16	N/A
6/30/2019	25	-19	-14	-13	N/A
3/31/2019	24	-16	-11	-11	N/A
12/31/2018	22	-11	-5	-5	N/A
9/30/2018	22	-10	-20	-20	N/A
6/30/2018	6	-31	-24	-24	N/A
3/31/2018	6	-41	-29	-29	N/A
12/31/2017	6	-42	-37	-37	N/A
9/30/2017	6	-57	-59	-59	N/A
6/30/2017	N/A	-70	-83	-83	N/A
3/31/2017	9	0	-120	-120	N/A
12/31/2016	19	-30	-155	-154	N/A
9/30/2016	28	-46	-52	-51	N/A
6/30/2016	119	15	N/A	-50	N/A
3/31/2016	114	-76	N/A	-36	N/A

Earnings vs Savings Rate: INFI is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: INFI is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: INFI is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: INFI's revenue (44.1% per year) is forecast to grow faster than the US market (6.9% per year).

High Growth Revenue: INFI's revenue (44.1% per year) is forecast to grow faster than 20% per year.

Future ROE: Insufficient data to determine if INFI's Return on Equity is forecast to be high in 3 years time